V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20157918 | 20060379 | 1.55 | 73 | Adjuvant (A) | 2018-11-24 | 2018-12-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100139903 |
| 20157919 | 20060380 | 1.61 | 78.3 | Adjuvant (A) | 2018-10-27 | 2018-10-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101437648 |
| 20157920 | 20060381 | 1.72 | 76.3 | Neo-adjuvant (N) | 2019-07-28 | 2019-07-28 | ECX | 02 | null | ECX | 100026354 |
| 20157922 | 20060382 | 1.89 | 51.8 | Neo-adjuvant (N) | 2018-09-15 | 2018-09-29 | ECX | 2 | N | ECX | 101848570 |
| 20157924 | 20060383 | 1.64 | 39.6 | Neo-adjuvant (N) | 2019-07-19 | 2019-07-29 | ECX | N | N | ECX | 100190449 |
| 20157926 | 20060384 | 1.78 | 91 | Palliative (P) | 2016-11-06 | 2016-11-07 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 101793123 |
| 20157927 | 20060385 | 1.8 | 73 | Adjuvant (A) | 2017-07-11 | 2017-08-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101683352 |
| 20157930 | 20060386 | null | 72 | Adjuvant (A) | 2019-07-03 | 2019-07-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101515703 |
| 20157931 | 20060387 | 1.65 | 69.4 | Adjuvant (A) | 2019-05-18 | 2019-06-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101582099 |
| 20157932 | 20060388 | 1.75 | 87.8 | Neo-adjuvant (N) | 2017-04-17 | 2017-04-17 | ECX | 02 | N | ECX | 100166520 |
| 20157933 | 20060389 | 1.59 | 64.7 | Neo-adjuvant (N) | 2019-10-10 | 2019-10-22 | ECX | N | N | ECX | 101657154 |
| 20157934 | 20060390 | 1.67 | 86.4 | Neo-adjuvant (N) | 2018-05-14 | 2018-05-18 | ECX | 02 | N | ECX | 101833811 |
| 20157936 | 20060391 | 1.88 | 49 | Neo-adjuvant (N) | 2019-07-14 | 2019-07-22 | ECX | 02 | null | ECX | 100579861 |
| 20157938 | 20060392 | 1.76 | 74.3 | Palliative (P) | 2017-03-07 | 2017-03-21 | CAPECITABINE + GEMCITABINE | N | Y | CAPECITABINE + GEMCITABINE | 100095027 |
| 20157939 | 20060393 | 1.82 | 103.9 | Neo-adjuvant (N) | 2018-09-05 | 2018-09-15 | ECX | 02 | Y | ECX | 100791280 |
| 20157941 | 20060394 | 1.66 | 78 | Palliative (P) | 2019-03-17 | 2019-03-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100855066 |
| 20157943 | 20060395 | 1.78 | 64 | Palliative (P) | 2018-09-27 | 2018-10-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100246091 |
| 20157945 | 20060396 | 1.7 | 66.7 | null | 2017-08-30 | 2017-09-17 | ECX | N | N | ECX | 101641808 |
| 20157952 | 20060397 | 1.65 | 72.2 | Palliative (P) | 2017-08-27 | 2017-08-31 | ECX | 02 | N | ECX | 100581928 |
| 20157955 | 20060398 | 1.55 | 55.8 | Palliative (P) | 2019-03-19 | 2019-03-30 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100332880 |
| 20157957 | 20060399 | 1.75 | 88.6 | Palliative (P) | 2016-09-19 | 2016-09-19 | ECX | 02 | N | ECX | 100854715 |
| 20157958 | 20060400 | 1.76 | 49.6 | Adjuvant (A) | 2019-11-15 | 2019-12-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100463445 |
| 20157960 | 20060401 | 1.62 | 58.15 | Neo-adjuvant (N) | 2019-09-03 | 2019-09-19 | ECX | N | N | ECX | 101025275 |
| 20157962 | 20060402 | 1.77 | 93.3 | Neo-adjuvant (N) | 2016-10-18 | 2016-10-18 | ECX | 02 | N | ECX | 101129451 |
| 20157963 | 20060403 | 1.9 | 63.8 | Palliative (P) | 2017-07-24 | 2017-08-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100360018 |
| 20157965 | 20060404 | 1.55 | 50.8 | Palliative (P) | 2017-11-03 | 2017-11-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100834243 |
| 20157966 | 20060405 | 1.71 | 82 | Curative (C) | 2019-08-09 | 2019-08-18 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 101615863 |
| 20157967 | 20060406 | 1.61 | 66.9 | Adjuvant (A) | 2019-06-22 | 2019-06-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100816752 |
| 20157969 | 20060407 | 1.8 | 65.5 | Adjuvant (A) | 2017-10-29 | 2017-11-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100521454 |
| 20157970 | 20060408 | 1.8 | 94.5 | Palliative (P) | 2017-08-15 | 2017-08-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101667785 |
| 20157972 | 20060409 | 1.72 | 63 | Neo-adjuvant (N) | 2016-05-07 | 2016-05-25 | ECX | N | Y | ECX | 101563351 |
| 20157974 | 20060410 | 1.56 | 71.7 | Palliative (P) | 2020-01-12 | 2020-01-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100957198 |
| 20157975 | 20060411 | 1.75 | 57.4 | Neo-adjuvant (N) | 2018-05-23 | 2018-06-06 | ECX | N | null | ECX | 100062280 |
| 20157978 | 20060412 | 1.71 | 67.8 | Adjuvant (A) | null | 2018-07-26 | ECX | N | N | ECX | 100941812 |
| 20157981 | 20060413 | 1.75 | 49 | null | 2016-07-28 | 2016-07-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101039603 |
| 20157983 | 20060414 | 1.63 | null | Palliative (P) | null | 2019-08-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100699688 |
| 20157984 | 20060415 | 1.63 | 115.4 | Neo-adjuvant (N) | 2018-07-03 | 2018-07-10 | ECX | 2 | null | ECX | 100699793 |
| 20157985 | 20060416 | null | null | null | 2016-01-12 | 2016-01-22 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100433565 |
| 20157987 | 20060417 | 1.67 | 57.2 | Adjuvant (A) | 2018-07-26 | 2018-07-31 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100903361 |
| 20157989 | 20060418 | 1.53 | 97.9 | Palliative (P) | 2018-10-13 | 2018-11-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101841836 |
| 20157990 | 20060419 | 1.7 | 71.7 | Adjuvant (A) | 2017-05-24 | 2017-05-28 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101853820 |
| 20157991 | 20060420 | 1.8 | 103 | Palliative (P) | 2017-10-25 | 2017-10-31 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100501774 |
| 20157992 | 20060421 | 1.77 | 82.3 | Adjuvant (A) | 2019-11-22 | 2019-12-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100963255 |
| 20157993 | 20060422 | 1.69 | 58.2 | Adjuvant (A) | 2018-05-21 | 2018-05-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101718925 |
| 20157996 | 20060423 | 1.75 | 71.8 | Adjuvant (A) | 2019-08-12 | 2019-09-04 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100048142 |
| 20157998 | 20060424 | 1.72 | 82.3 | Neo-adjuvant (N) | 2019-01-29 | 2019-01-29 | ECX | N | N | ECX | 101466930 |
| 20157999 | 20060425 | 1.85 | 85.8 | Palliative (P) | 2018-12-09 | 2018-12-23 | ECX | N | N | ECX | 101150893 |
| 20158001 | 20060426 | 1.58 | 42 | Neo-adjuvant (N) | 2016-10-27 | 2016-11-03 | ECX | N | N | ECX | 100046755 |
| 20158002 | 20060427 | 1.58 | 50.8 | Neo-adjuvant (N) | 2019-01-25 | 2019-02-08 | ECX | 02 | N | ECX | 100303878 |
| 20158003 | 20060428 | 1.73 | 100.9 | null | 2019-03-20 | 2019-03-31 | ECX | N | N | ECX | 100920320 |